SMT201400189B - Composizione per indurre una rigenerazione tissutale tramite attivazione del plasma ricco di piastrine (prp), e metodo per la sua preparazione - Google Patents

Composizione per indurre una rigenerazione tissutale tramite attivazione del plasma ricco di piastrine (prp), e metodo per la sua preparazione

Info

Publication number
SMT201400189B
SMT201400189B SM201400189T SM201400189T SMT201400189B SM T201400189 B SMT201400189 B SM T201400189B SM 201400189 T SM201400189 T SM 201400189T SM 201400189 T SM201400189 T SM 201400189T SM T201400189 B SMT201400189 B SM T201400189B
Authority
SM
San Marino
Prior art keywords
prp
platelet
activation
preparation
composition
Prior art date
Application number
SM201400189T
Other languages
English (en)
Inventor
Hyun-Shin Park
Ji-Chul Yu
Ju-Hee Park
Jang-Hoon Kim
Hun Kim
Sae-Bom Lee
Jae-Deog Jang
Cheong-Ho Jang
Original Assignee
Sewon Cellontech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd
Publication of SMT201400189B publication Critical patent/SMT201400189B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
SM201400189T 2009-10-23 2014-12-18 Composizione per indurre una rigenerazione tissutale tramite attivazione del plasma ricco di piastrine (prp), e metodo per la sua preparazione SMT201400189B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090101387A KR101114712B1 (ko) 2009-10-23 2009-10-23 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법
PCT/KR2009/006745 WO2011049263A1 (ko) 2009-10-23 2009-11-17 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물 및 그 제조방법

Publications (1)

Publication Number Publication Date
SMT201400189B true SMT201400189B (it) 2015-01-15

Family

ID=43900476

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400189T SMT201400189B (it) 2009-10-23 2014-12-18 Composizione per indurre una rigenerazione tissutale tramite attivazione del plasma ricco di piastrine (prp), e metodo per la sua preparazione

Country Status (18)

Country Link
US (1) US9011929B2 (it)
EP (1) EP2491961B1 (it)
JP (1) JP5550732B2 (it)
KR (1) KR101114712B1 (it)
CN (1) CN102573943B (it)
AU (2) AU2009354233B2 (it)
BR (1) BR112012009560B8 (it)
CA (1) CA2778351C (it)
CY (1) CY1115850T1 (it)
DK (1) DK2491961T3 (it)
ES (1) ES2526759T3 (it)
HR (1) HRP20141098T1 (it)
MX (1) MX2012004635A (it)
PL (1) PL2491961T3 (it)
PT (1) PT2491961E (it)
SI (1) SI2491961T1 (it)
SM (1) SMT201400189B (it)
WO (1) WO2011049263A1 (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442242B1 (es) * 2012-08-09 2014-11-25 Biotechnology Institute, I Mas D, S.L. Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
ES2883580T3 (es) 2013-03-21 2021-12-09 Collplant Ltd Composiciones que comprenden colágeno y PRP para la regeneración de tejidos y su método de producción
KR101495449B1 (ko) * 2013-11-12 2015-02-23 전북대학교산학협력단 혈소판 패치의 제조 방법
US9708597B2 (en) * 2014-01-17 2017-07-18 General Electric Company Electric pulse generation systems using capacitive coupling
US10421956B2 (en) 2014-01-17 2019-09-24 General Electric Company Electric pulse generation systems using capacitive coupling
US9452199B2 (en) * 2014-01-17 2016-09-27 General Electric Company Platelet activation and growth factor release using electric pulses
CN104587525A (zh) * 2014-12-19 2015-05-06 深圳中元生物科技有限公司 包含血小板及透明质酸的支架及其制备方法
JP6875619B2 (ja) * 2015-02-26 2021-05-26 株式会社細胞応用技術研究所 多血小板血漿の保存方法
EP3316780B1 (en) * 2015-07-02 2020-12-02 Arthrex, Inc. Methods for preparation of enriched biological fluids
KR20170006820A (ko) 2015-07-10 2017-01-18 주식회사 글로원 혈소판 농축 방법 및 이를 위한 농축기구
WO2017082441A1 (ko) * 2015-11-13 2017-05-18 중부대학교 산학협력단 활성화된 혈소판 풍부 혈장을 유효성분으로 포함하는 동물의 창상 치료용 수의학적 조성물
JP7333272B2 (ja) 2017-01-11 2023-08-24 スパイナルサイト， エルエルシー 線維芽細胞治療活性を増強する方法
CN108619497A (zh) * 2017-03-23 2018-10-09 黄丽伟 一种可以促进皮肤胶原再生的组合物及其制备方法和应用
CN107349468B (zh) * 2017-07-02 2020-12-04 江西瑞济生物工程技术股份有限公司 一种羊膜干细胞凝胶及其制备方法和应用
US10968423B2 (en) 2018-02-26 2021-04-06 General Electric Company System and method for electric pulse based activation of biological samples
TW201936627A (zh) * 2018-02-26 2019-09-16 鄭本岡 具有高活化細胞因子的血清之備製方法
CN109513045B (zh) * 2018-11-20 2021-01-15 温州生物材料与工程研究所 具有双层不同内部孔径结构的蛋白基水凝胶及其制备方法
CN111249527A (zh) * 2018-12-03 2020-06-09 陕西佰傲再生医学有限公司 一种富血小板血浆的软组织填充剂及其制备方法
EP3976109A4 (en) * 2019-05-24 2023-01-25 KNOW Bio, LLC PHOTOACTIVATED BLOOD PRODUCTS AND METHODS AND APPARATUS FOR MAKING AND USING SAME
CN110478531A (zh) * 2019-08-02 2019-11-22 中南大学湘雅医院 一种富血小板血浆组织工程支架及其制备方法
CN111110915A (zh) * 2020-02-28 2020-05-08 珠海中信大有科技有限公司 用于构建肌骨组织的自体生长因子补片的制作方法及应用
IT202000024385A1 (it) * 2020-10-15 2022-04-15 Biomedical Res Srl Composizione a base di concentrati piastrinici autologhi e di una miscela di fattori biologici isolata dal colostro per l’uso nel trattamento di condizioni che richiedono la riparazione e la rigenerazione tessutale
CN113244458B (zh) * 2021-05-08 2022-07-08 康膝生物医疗(深圳)有限公司 一种用于修复关节软骨损伤的复合材料及其制备方法
CN113577387A (zh) * 2021-06-09 2021-11-02 康膝生物医疗(深圳)有限公司 一种复合prp和胶原蛋白的温敏水凝胶制备方法及应用
CN114288472A (zh) * 2021-12-07 2022-04-08 武汉亚洲生物材料有限公司 一种基于富血小板血浆的人工骨修复材料及制备方法
WO2023196787A2 (en) * 2022-04-04 2023-10-12 Vascudyne, Inc. Improved constructed tissue
CN115400270A (zh) * 2022-09-08 2022-11-29 南开大学 缓释富血小板血浆的复合支架材料及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998057678A2 (en) * 1997-06-18 1998-12-23 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen
US6322785B1 (en) * 1999-03-02 2001-11-27 Natrex Technologies Methods and compositions for bone graft implants
KR20020012170A (ko) * 1999-04-02 2002-02-15 추후제출 폴리산과 폴리에테르의 조성물 및 이들을 유착 방지에이용하는 방법
KR100880622B1 (ko) * 2000-06-29 2009-01-30 바이오신텍 캐나다 인코포레이티드 연골 및 다른 조직의 복구 및 재생용 조성물 및 방법
DE10360628A1 (de) * 2003-12-19 2005-07-21 Dade Behring Marburg Gmbh Kontrollplasma für Thrombinaktivitätstests
WO2006129703A1 (ja) * 2005-05-31 2006-12-07 Kurume University 活性化部分トロンボプラスチン時間の検査方法
US8052969B2 (en) * 2006-12-28 2011-11-08 Arthrex, Inc. Method of making plasma enriched with platelets using a double syringe system where the second sytringe is within the first syringe and use thereof
ES2333498B1 (es) 2007-08-02 2011-01-10 Biotechnology Institute, I Mas D, S.L. Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.

Also Published As

Publication number Publication date
CY1115850T1 (el) 2017-01-25
PL2491961T3 (pl) 2015-03-31
HRP20141098T1 (hr) 2015-02-13
BR112012009560B8 (pt) 2021-06-22
EP2491961A1 (en) 2012-08-29
BR112012009560A2 (pt) 2020-11-17
KR20110044615A (ko) 2011-04-29
AU2009354233A1 (en) 2012-06-07
JP5550732B2 (ja) 2014-07-16
CN102573943B (zh) 2015-04-08
CA2778351C (en) 2015-06-09
AU2014210601A1 (en) 2014-08-28
EP2491961B1 (en) 2014-10-01
DK2491961T3 (en) 2014-12-01
CN102573943A (zh) 2012-07-11
US20120201897A1 (en) 2012-08-09
CA2778351A1 (en) 2011-04-28
ES2526759T3 (es) 2015-01-15
US9011929B2 (en) 2015-04-21
PT2491961E (pt) 2014-11-14
KR101114712B1 (ko) 2012-02-29
WO2011049263A1 (ko) 2011-04-28
MX2012004635A (es) 2012-07-30
SI2491961T1 (sl) 2015-01-30
BR112012009560B1 (pt) 2021-03-09
JP2013508066A (ja) 2013-03-07
AU2009354233B2 (en) 2014-08-28
EP2491961A4 (en) 2013-09-04

Similar Documents

Publication Publication Date Title
SMT201400189B (it) Composizione per indurre una rigenerazione tissutale tramite attivazione del plasma ricco di piastrine (prp), e metodo per la sua preparazione
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
EP2737871A4 (en) MEMBRANE FOR ALVEOLARY BONE REGENERATION
BRPI0911176A2 (pt) Métodos de extinção melhorados para inativação de patógeno de células vermelhas sanguíneas
CL2014000245A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de replicacion de los virus de influenza; metodo de preparacion; composicionn farmaceutica; metodo para inhibir la replicacion del virus de la influenza en una muestra biológica o un paciente.
CL2014002904A1 (es) Una composición geopolimérica de aluminosilicato; metodo de preparacion.
IL229583B (en) A preparation obtained by a process for the purification of coagulation factor viii
CO6960551A2 (es) Derivados nucleósidos con sustitución 2,4-difluoro -2-metilo como inhibidores de la replicación del arn del vch
EP2334328A4 (en) METHOD FOR CLEANING VIRUSES
CO6791570A2 (es) Nueva cepa del prrsv europea
DK2976097T3 (da) Sammensætninger, som omfatter kollagen og prp, til vævsregenerering og fremgangsmåde til fremstilling deraf
BR112014010164A2 (pt) implante de tecido duro
DK2308325T4 (da) Fremgangsmåde til højtryksbehandling af produkter
BR112013024520A2 (pt) método para preparar uma composição adsorvente,em, dispositivo de purificação de àgua
BR112012013954A2 (pt) derivado de ácido hialurônico, método de preparação do derivado de ácido hialurônico e método de modificação do derivado de ácido hialurônico
BR112013012309A2 (pt) composto, composição, métodos de tratamento e usos de um composto
BR112012023355A2 (pt) composto, composição farmacêutica e método de ruptura da interação nek2/hec1
EP2762174A4 (en) COMPOSITION FOR BONE REGENERATION
CO6821934A2 (es) Composición de androgeno para tratar una afección oftalmica
ITTO20110630A1 (it) Composizioni farmaceutiche di combinazione e metodo per trattare vertigini, cinetosi e distonia vascolare vegetativa
IT1397924B1 (it) Procedimento per il recupero di oli da una matrice solida.
WO2012145254A9 (en) Methods of using inhibitors of rorϒt to treat disease
CO6811865A2 (es) Método de tratamiento de la fiebre dengue
CL2013000831A1 (es) Metodo para la determinacion del contenido de alergenos de una composicion.
GT201100300A (es) Piperidinas sustituidas